WHC is still in active development. Read this to understand our approach.
depiction of GJSURZIOUXUGAL-UHFFFAOYSA-N.svg
tripsit

clonidine

Check on tripsit

psychonaut

Clonidine

Check on psychonaut

isomerdesign

Clonidine

Check on isomerdesign

pubchem

Clonidine

Check on pubchem

druglab

Clonidine

Check on druglab

drugmap

Clonidine

Check on drugmap

wiki

Clonidine

Check on wiki

Data

InChI: InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)

Synonyms: 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine,CCRIS 7787,Lopac0_000268,1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-,NCGC00015268-07,DSSTox_GSID_22846,Clonidinum,CHEMBL134,Catarpres-TTS (TN),2-(2,6-Dichlorophenylimino)imidazolidine,Catapres- TTS,Catapres,2-[(2,6-dichlorophenyl)imino]-imidazolidine,Spectrum5_000759,CLONIDINE [USP-RS],Adesipress, Duraclont,4205-90-7,SDCCGSBI-0050256.P005, Clofenil,CLONIDINE, Clonidine hydrochloride, CLORPRES,HMS1791P10,ST 155BS,clonidine (imino form),Prestwick3_000248,Chlofazoline,Clonidine,AB00514634_09,KBio2_006957,M-5041T,BSPBio_002055, N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine,KBioGR_001572, Catarpres-TTS (TN),ST-155BS,CLONIDINE [MART.],734571A,SPBio_001233,BCP07223, ST 155BS,Prestwick0_000248,CLONIDINE [HSDB],L000193,DSSTox_CID_2846, CATAPRES-TTS-3,Lopac-C-7897, Catapres,Prestwick2_000248, Clopheline, Gemiton,IDI1_034058,CLONIDINE [VANDF],2-(2',6'-dichlorophenylamino)-2-imidazoline,CATAPRES-TTS-1,CLONIDINE [INN],CLONIDINE [MI], Duraclon,Clonidin, 2-[(2,6-dichlorophenyl)imino]-2-imidazoline,NCGC00024734-03,HMS1361P10,KBio2_002876,Bio1_001448,BRD-K98530306-003-05-0,NCGC00015268-05,BRD-K98530306-003-07-6, Clonidina [INN-Spanish],clonidine (amino form),MN3L5RMN02, Isoglaucon,2,6-dichloro-N-imidazolidin-2-ylideneaniline,CLONIDINE [ORANGE BOOK], Catarpresan,1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI),HSDB 3040,KBio2_005444,Bio1_000470,NCGC00015268-04,CLONIDINE [JAN], Clonidine [USAN:BAN:INN],NCGC00024734-05,FT-0741246, ST-155-BS,KBioSS_001821,Tox21_110118_1,BSPBio_001588,2-(2,6-dichlorophenylimino)-imidazolidine,2-[(2,6-Dichlorophenyl)imino]imidazoline,NCGC00179680-05, ST-155BS, Clonidina,CS-0012297, 2,6-dichloro-N-2-imidazolidinylidenebenzenamide,Catarpresan, Hemiton,BDBM50016897,SR-01000759380,Chlornidinum, Adesipress,N-(2,6-dichlorophenyl)imidazolidin-2-imine,N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine, 2-(2,6-Dichlorophenylamino)-2-imidazoline, 2-(2,6-Dichloroanilino)-2-imidazoline, 4205-90-7,AB00514634-08,Clonidinhydrochlorid,Clonidina,Bio1_000959, Catapresan,BBL025137, 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine,CCG-204363,NCGC00015268-06, M 5041T,Prestwick1_000248,BIDD:GT0547, Klofenil, 734571A,DB00575, Catarpres, Dixarit,Catapres-TTS, 2,6-dichloro-N-(2-imidazolidinylidene)aniline,2-((2,6-Dichlorophenyl)imino)imidazolidine,BPBio1_000040,Clonidine [USAN:USP:INN:BAN],NCGC00024734-04,SCHEMBL5982,BDBM50225285,CHEBI:46632,CHEBI:3757, CATAPRES-TTS-2,DSSTox_RID_76756,Benzenamine, 2,6-dichloro-N-2-imidazolidinylidene-,KBio2_001821,CATAPRES-TTS-3, Catapres-TTS, Clonidinum,starbld0009556,HY-12721,2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2),UNII-MN3L5RMN02,Catapresan,clonidine, clonidine (amino form),NCGC00015268-02,ZINC896484,NCGC00015268-12, 2,6-DICHLORO-N-IMIDAZOLIDIN-2-YLIDENEANILINE,MLS006011925,[3H]clonidine,AKOS015960367, Catapres- TTS,Clonidine solution,M 5041T,Tox21_110118, Clonidine (JAN/USAN/INN),NCGC00015268-08,kapvay,NCGC00179680-03,D00281, M-5041T,Tocris-0690,DivK1c_000774, Clonidinhydrochlorid,Q412221, Klofelin,ST-155-BS,CLONIDINE [WHO-DD], 2-(2,6-Dichlorophenylimino)imidazolidine,BRD-K98530306-001-02-1, 2-Imidazoline, 2-(2,6-dichloroanilino)-(7CI,8CI),Spectrum3_000358,SPBio_002255, 1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-(9CI),HMS3402P10,GTPL516,KBioSS_000308, Clonidin,Spectrum_001341,2-[(2,6-dichlorophenyl)imino]-2-imidazoline,Duraclon,AKOS001595470,2,6-dichloro-N-2-imidazolidinylidenebenzenamide,IDI1_000774, 2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2), Catapres (TN),4205-90-7 (free base),2-(2,6-Dichloroanilino)-2-imidazoline, Catapressan,Catapressan,KBioGR_000308,CLORPRES,SR-01000759380-4,Nexiclon,Catarpres-TTS,KBio3_000616,NCGC00179680-02,Catarpres,CLONIDINE [USP MONOGRAPH],2-Imidazoline, 2-(2,6-dichloroanilino)-,(2,6-Dichlorophenyl)imidazolidin-2-ylidene amine,HMS2089G11,Bio2_000308,Spectrum2_001187,Clonidinum [INN-Latin],Kapvay&reg,NCGC00179680-01,KBio3_000615,NCGC00024734-02,2-(2,6-dichlorophenyl-imino)-imidazolidine,BSPBio_000036,EINECS 224-119-4,AB00053441_03,HMS1989P10,EN300-8686697, 2-((2,6-Dichlorophenyl)imino)imidazolidine,KBio2_004389,Clonidina [INN-Spanish],BDBM14062,KBio3_001275,NCGC00015268-01, Chlornidinum,57066-25-8, Adesipress,Clonidine (JAN/USP/INN),Clonidine extended release,F74813,CLONIDINE(200MG),2-(2,6-Dichlorophenylamino)-2-imidazoline, Clonidinum [INN-Latin],N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine #,KBio1_000774, SKF 34427,NCGC00015268-03,CAS-4205-90-7, 2,6-dichloro-N-imidazolidin-2-ylideneaniline,CAS-4205-91-8,2-[(2,6-Dichlorophenyl)imino]imidazolidine,CLONIDINE [USAN],DTXCID402846,3h-clonidine,STL355995,Spectrum4_000956,SKF 34427, Catarpres-TTS,Clonidine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,duraclon,Nexiclon XR,SBI-0050256.P004,NCGC00024734-01,AB00514634-07,(2,6-dichloro-phenyl)-imidazolidin-2-ylidene-amine, Tenso-Timelets,MRF-0000018,catapres,Combipres, 2-[(2,6-Dichlorophenyl)imino]imidazoline,CATAPRES-TTS-2, CATAPRES-TTS-1,2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI),Bio2_000788,DTXSID6022846,SMR001550184,AB00514634,2-IMIDAZOLINE, 2-(2,6-DICHLOROPHENYLAMINO)-,NINDS_000774,Clonidine(200 mg),KBio2_000308

Estimated data

Solubility: -2.984 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 40.2% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.